October 14, 2019
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link f or your convenience.

 

NRG Oncology seeking applications for travel awards for the next NRG Meeting in January 2020


Application Deadline: 10/25/19

 

  Read more

 


ACTIVATION

GYNECOLOGIC

NRG-GY021: Activation October 11, 2019; version date: October 2, 2019 (posted on  CTSU)


AMENDMENTS
GASTROINTESTINAL

NRG-GI002: Amendment 3; version date: June 4, 2019 (posted on CTSU)

GYNECOLOGIC

NRG-GY014: Amendment 1; version date: August 13, 2019 (posted on CTSU)


OTHER PROTOCOL NOTICES

1. GASTROINTESTINAL

NRG-GI004: E-mail Blast (posted on CTSU)

 

2. GYNECOLOGIC

NRG-GY004: Preparation for Upcoming Database Lock and Analysis memo (posted on CTSU)

NRG-GY005: CEC Whole Blood Shipping Address memo (posted on  CTSU)


NRG-GY009: Block Submission Reminder memo (posted on CTSU)

 

NRG-GY018: MMR and PD-L1 Kit Ordering (memo posted on CTSU)


Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus Read more

 

Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment Read more

 

3. VTOC TRAINING

The  VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, November 13.

 

 

DRUG SAFETY AND INVESTIGATOR BROCHURE (IB) UPDATES

Safety updates and IB Notices have been issued for the following studies:

 

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

IB*

Atezolizumab

NRG-LU005

NRG-GY009

NRG-GY017

CTSU

CTSU

NRG

X

X

X

Olaparib

NSABP B-55

CTSU

 

 

 *The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website ( https://ctepcore.nci.nih.gov/OAOP/).  Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

 

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

 

 

 

NRG Oncology seeking applications for travel awards for the next NRG Meeting in January 2020

NRG Oncology, in partnership with the RTOG Foundation, NSABP Foundation, and GOG Foundation, seek to support attendees to the NRG Oncology Semiannual meeting occurring January 9-11, 2020 at the Marriott Marquis in Houston, TX. Meeting registration will be opening soon! Applications for travel awards are due by the close of business October 25, 2019 and applicants will be notified by November 22, 2019 if they have been selected for an award. The travel award application is posted here.

NRG-BN006 Training Sessions

Two investigator sessions for NRG-BN006 have been scheduled in conjunction with upcoming neuro-oncology/surgical annual meetings:

  • Congress of Neurological Surgeons (CNS) Annual Meeting in San Francisco, CA, Oct 20, 2019, 2:00-4:00 pm.
  • Society of Neuro-Oncology (SNO) Annual Meeting in Phoenix, AZ, Nov 22, 2019, 6:30-9:00 pm.

NRG-BN006 is a phase II/III randomized, open-label study of Toca 511, a retroviral replicating vector, combined with Toca FC with temozolomide and radiation followed by adjuvant temozolomide and Toca FC compared to temozolomide and radiation followed by adjuvant temozolomide in patients with newly diagnosed glioblastoma. Activation for this study is planned within the next two months.

Please RSVP to https://www.surveymonkey.com/r/NRG_BN006_Training_Response if you plan to attend either of these meetings. Room assignments will be provided at a later date.

 

NRG Oncology seeking an experienced Patient Advocate to serve as Chair for its Patient Advocate Committee

This volunteer position provides the selected individual the responsibility of facilitating and guiding the NRG Oncology Patient Advocate Committee (PAC) and program through a process to update its vision and create an action plan to build on its success. Read more

 

PSC Accepting Applications for CTN and CRA Committees and Working Groups
The NRG Oncology Protocol Support Committee (PSC) is accepting applications for membership on the Clinical Trial Nurse (CTN) Committee, Clinical Research Associate (CRA) Committee, and PSC Working Groups (Education and Training, Mentorship, Protocol Review, and Quality Control). CTN and CRA members must also be a member of a Working Group. If you are not currently a member of a working group, you may apply at the same time.

 

If you are interested in becoming a member of any of the committees or groups mentioned above, the Application Request forms, including instructions and descriptions, are posted here. Each application is posted as Word .doc, Word .docx, and PDF formats (login required to download the forms).

 

Applications are to be submitted by Monday, October 21, 2019. Please forward questions to: NRG-PSC@nrgoncology.org

 

Call for Research Proposals

The NRG Oncology Colorectal Cancer subcommittee is seeking vendors and researchers with ctDNA expertise in the field.  An RFA for the randomized phase II/III colorectal prospective clinical trial, NRG-CR1902 is posted here. We are seeking a biomarker assay partner to perform CLIA-certified assay testing of patients to detect ctDNA from plasma samples at the time of enrollment and at end of completion of planned adjuvant therapy.  Responses to the RFA no later than Friday, November 1, 2019. Please direct responses and any questions to Chet Cornman at chet.cornman@nsapb.org.

 

PUBLICATIONS REMINDERS

Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

European Society of Gynaecological Oncology (ESGO)  Biennial Nov 2-5, 2019; Athens, Greece

International Society for Quality of Life Research (ISOQOL); Oct 20-23, 2019; San Diego, CA

 

Radiological Society of North America (RSNA); Dec 1-6, 2019; Chicago, IL

San Antonio Breast Cancer Symposium (SABCS); Dec 10-14, 2019; San Antonio, TX

Society for Neuro-Oncology (SNO); Nov 20-24, 2019; Phoenix, AZ


Upcoming Abstract Submission Deadlines

American Association for Cancer Research (AACR); Apr 24-29, 2020; San Diego, CA; due to publications committee Nov 21, 2019; meeting submission deadline Dec 5, 2019; LBA Jan , 2020

American Association for Thoracic Surgery (AATS); Apr 25-28, 2020; New York, NY; meeting submission deadline Oct 15, 2019

American Society of Clinical Oncology (ASCO) GU; Feb 13-15, 2020; San Francisco, CA; meeting submission deadline Oct 22, 2019

European Society for Radiotherapy and Oncology (ESTRO); Apr 3-7, 2020; Vienna, Austria; meeting submission deadline Oct 23, 2019; Late submission Jan 15, 2020

Society of Gynecologic Oncology (SGO); Mar 28-31, 2020; Toronto, ON Canada; submission deadline  Intl abstr  11-5-19; LBA 1-7-20

NRG Oncology is proud to be an active participant of #CancerMoonShot.
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse